Alzheimers Early Detection
Detecting Alzheimer's Disease early is critical for effective management. Symptoms like disruptive memory loss, challenges in problem-solving, confusion with time or place, and difficulty completing tasks are key indicators. Other signs include social withdrawal, mood changes, and spatial relationship difficulties. Diagnostic tests such as cognitive assessments, brain imaging, and genetic testing confirm the disease. Early detection enables timely interventions like medication, lifestyle adjustments, and support services, which can slow progression and enhance quality of life for those with Alzheimer's and related dementias, as well as their families.
Committee Members
Jacqueline Tuppen
Cogs Club, United Kingdom
Yong Xiao Wang
Albany Medical College, United States
Kaoru Sakatani
The University of Tokyo, Japan Dementia 2023 Speakers
Suren A Tatulian
University of Central Florida, United States
Constantina Mizis
The Latino Alzheimer’s and Memory Disorders Alliance, United States
Paul Y Song
NKGen Biotech, United States
Marco Ruggiero
Silver Spring Sagl, Switzerland
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States